Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 02:51:53 2024-04-19 pm EDT 5-day change 1st Jan Change
365.3 USD -1.96% Intraday chart for Intuitive Surgical, Inc. -4.76% +8.64%
Sales 2024 * 8.01B Sales 2025 * 9.27B Capitalization 132B
Net income 2024 * 1.95B Net income 2025 * 2.24B EV / Sales 2024 * 15.9 x
Net cash position 2024 * 4.86B Net cash position 2025 * 7.81B EV / Sales 2025 * 13.4 x
P/E ratio 2024 *
70.1 x
P/E ratio 2025 *
60.5 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.25%
1 week-2.88%
Current month-6.36%
1 month-4.31%
3 months-0.30%
6 months+36.66%
Current year+10.77%
More quotes
1 week
369.15
Extreme 369.15
392.29
1 month
369.15
Extreme 369.15
403.76
Current year
320.26
Extreme 320.26
403.76
1 year
254.85
Extreme 254.85
403.76
3 years
180.07
Extreme 180.07
403.76
5 years
120.17
Extreme 120.1667
403.76
10 years
38.50
Extreme 38.4956
403.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 69 18-07-30
Director/Board Member 66 07-10-18
More insiders
Date Price Change Volume
24-04-19 366 -1.79% 2 625 171
24-04-18 372.6 -0.41% 2,320,460
24-04-17 374.2 -1.16% 1,625,645
24-04-16 378.6 +0.32% 1,602,985
24-04-15 377.4 -1.93% 1,650,717

Delayed Quote Nasdaq, April 19, 2024 at 09:58 am EDT

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
372.6 USD
Average target price
418.1 USD
Spread / Average Target
+12.20%
Consensus